Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Product Life Cycle Limits May Level Playing Field For Generics - TCI's DiCicco

Executive Summary

Legislation that would limit branded product life cycle management strategies could level the playing field for generic drug products, Technology Catalysts International President Richard DiCicco said at the International Generic Drug Forum Jan. 24 in Washington, D.C.

You may also be interested in...



ANDA User Fee Creation Is Among Top NAPM Legislative Issues For 2000

The National Association of Pharmaceutical Manufacturers will press for the creation of generic drug user fees during the second session of the 106th Congress.

ANDA User Fee Creation Is Among Top NAPM Legislative Issues For 2000

The National Association of Pharmaceutical Manufacturers will press for the creation of generic drug user fees during the second session of the 106th Congress.

Waxman/Hatch Debate Moves Forward: Generic Biologics Not Ruled Out

A generic approval process for biological product is being recognized as one item for consideration in reform of the Waxman/Hatch Act by the law's key sponsor in the Senate.

UsernamePublicRestriction

Register

OM007836

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel